<DOC>
	<DOCNO>NCT00753142</DOCNO>
	<brief_summary>Obesity common African-American patient newly diagnose diabetes present diabetic ketoacidosis ( DKA ) .1 Despite presentation severe symptom insulinopenia ketoacidosis , clinical immunogenetic observation indicate obese AA patient DKA type 2 diabetes . In patient , previous study reveal : ) presentation , obese AA patient DKA markedly de-creased pancreatic insulin secretion , low obese non-DKA patient admit comparable hyperglycemia , significantly great lean patient DKA ; 2 b ) aggressive diabetic management result significant improvement b-cell function insulin sensitivity sufficient allow discontinuation insulin therapy within 3 month follow-up.2 , 3 Based observation conclude similar obese patient hyperglycemia , obese AA DKA type 2 diabetes , although defect insulin secretion insulin action present , transient b-cell failure primary defect development ketoacidosis .</brief_summary>
	<brief_title>Mechanism Underlying Beta-cell Failure Obese African Americans With History Hyperglycemic Crises</brief_title>
	<detailed_description>Obese AA patient history DKA later experience near-normoglycemia remission represent ideal population define sequence event lead b-cell dysfunction type 2 diabetes . We hypothesize obese AA DKA prove particularly susceptible b-cells dysfunction due sustain elevation plasma glucose ( glucose toxicity ) and/or free fatty acid level ( lipotoxicity ) .</detailed_description>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Soybean oil , phospholipid emulsion</mesh_term>
	<criteria>1 . Obese African American subject ( BMI equal great 30 ) 2. age 1865 , 3. patient history diabetic ketoacidosis define ADA criterion 4. patient admit hyperglycemia without ketoacidosis ( BG great 400ml/dl without evidence ketosis/ketones 5. obese nondiabetic control ( BMI &gt; 30 ; rule diabetes 75g oral glucose tolerance test ) 1. patient positive autoimmune marker [ islet cell ( ICA ) Glutamic acid decarboxylase ( GAD ) autoantibodies ] ; 2. patient significant medical surgical illness , include limited myocardial ischemia , congestive heart failure , chronic renal insufficiency , liver failure , infectious process ; 3. patient recognize suspected endocrine disorder associate increased insulin resistance , hypercortisolism , acromegaly , hyperthyroidism ; 4. patient bleed disorder , thrombocytopenia , abnormality coagulation study ; 5. patient fast hyperglycemia ( blood glucose &gt; 120 mg/dl ) discontinuation insulin therapy , 6 ) pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Hyperglycemia</keyword>
</DOC>